Literature DB >> 30191030

Identifying patients at risk from nonalcoholic fatty liver-related hepatocellular carcinomas.

Mehmet Sayiner1,1, Zobair M Younossi1,2,1,2.   

Abstract

Entities:  

Keywords:  NAFLD; NASH; hepatocellular carcinoma; risk factors; surveillance

Year:  2016        PMID： 30191030      PMCID： PMC6095300          DOI： 10.2217/hep-2016-0002

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN： 2045-0923


× No keyword cloud information.
  17 in total

1.  Editorial: hepatocellular carcinoma in type 2 diabetes: more than meets the eye.

Authors:  György Baffy
Journal:  Am J Gastroenterol       Date:  2012-01       Impact factor: 10.864

2.  Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease.

Authors:  Alita Mishra; Zobair M Younossi
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

3.  Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.

Authors:  Y-L Liu; G L Patman; J B S Leathart; A-C Piguet; A D Burt; J-F Dufour; C P Day; A K Daly; H L Reeves; Q M Anstee
Journal:  J Hepatol       Date:  2014-03-06       Impact factor: 25.083

Review 4.  Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis.

Authors:  Pegah Golabi; Mehmet Sayiner; Yousef Fazel; Aaron Koenig; Linda Henry; Zobair M Younossi
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-10-15       Impact factor: 3.869

5.  Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.

Authors:  Judith Ertle; Alexander Dechêne; Jan-Peter Sowa; Volker Penndorf; Kerstin Herzer; Gernot Kaiser; Jörg F Schlaak; Guido Gerken; Wing-Kin Syn; Ali Canbay
Journal:  Int J Cancer       Date:  2011-03-14       Impact factor: 7.396

Review 6.  Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Problem of Growing Magnitude.

Authors:  Christine Pocha; Philippe Kolly; Jean-Francois Dufour
Journal:  Semin Liver Dis       Date:  2015-09-17       Impact factor: 6.115

7.  Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.

Authors:  Suzanne van Meer; Karel J van Erpecum; Dave Sprengers; Minneke J Coenraad; Heinz-Josef Klümpen; Peter L M Jansen; Jan N M IJzermans; Joanne Verheij; Carin M J van Nieuwkerk; Peter D Siersema; Robert A de Man
Journal:  Eur J Gastroenterol Hepatol       Date:  2016-03       Impact factor: 2.566

Review 8.  Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.

Authors:  György Baffy; Elizabeth M Brunt; Stephen H Caldwell
Journal:  J Hepatol       Date:  2012-02-09       Impact factor: 25.083

9.  Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.

Authors:  Paolo Sorrentino; Salvatore D'Angelo; Umberto Ferbo; Pietro Micheli; Alessandra Bracigliano; Raffaela Vecchione
Journal:  J Hepatol       Date:  2008-11-14       Impact factor: 25.083

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
View more
  3 in total

Review 1.  Hepatocellular carcinoma and non-alcoholic fatty liver disease.

Authors:  Pegah Golabi; Logan Rhea; Linda Henry; Zobair M Younossi
Journal:  Hepatol Int       Date:  2019-11-07       Impact factor: 6.047

2.  Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States.

Authors:  James M Paik; Pegah Golabi; Rakesh Biswas; Saleh Alqahtani; Chapy Venkatesan; Zobair M Younossi
Journal:  Hepatol Commun       Date:  2020-04-04

3.  Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series.

Authors:  Regiane Saraiva de Souza Melo Alencar; Claudia P Oliveira; Aline Lopes Chagas; Leonardo Gomes da Fonseca; Claudia Maccali; Lisa Rodrigues da Cunha Saud; Mariana Pinheiro Xerfan; Jose Tadeu Stefano; Paulo Herman; Luiz Augusto Carneiro D'Albuquerque; Venâncio Avancini Ferreira Alves; Flair Jose Carrilho
Journal:  Clinics (Sao Paulo)       Date:  2022-09-07       Impact factor: 2.898
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.